Last updated on: 7/8/2008 | Author:

Andrea Barthwell, MD Biography

Former Deputy Director at the U.S. Office of National Drug Control Policy
Con to the question "Should Marijuana Be a Medical Option?"

“It is not a medicine. You don’t know what’s in it. If there were compelling scientific and medical data supporting marijuana’s medical benefits that would be one thing. But the data is not there.”

Speech in Belleville, Illinois, Feb. 8, 2005

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Founder and Chief Executive Officer, EMGlobal LLC, a global health care and policy-consulting firm, 2005-Present
  • Consultant, GW Pharmaceuticals & Bayer to win approval for Sativex in the U.S., 2005-Present
  • Deputy Director for Demand Reduction, White House Office of National Drug Control Policy (ONDCP), 2002-2005
  • Recipient, Betty Ford Award, 2003
  • Fellow, American Society of Addiction Medicine
  • Former President, American Society of Addiction Medicine
  • Board of Directors, Coalition to End Needless Death on Our Roadways (END)
  • Founding Member, Chicago Area AIDS Task Force
  • Member, White House Task Force on Disadvantaged Youth
  • Member, White House Domestic Violence Working Group
  • Post-graduate training, University of Chicago & Northwestern University Medical Center
  • MD, University of Michigan Medical School
  • BA, Psychology, Wesleyan University
  • None found
Quoted in:
  1. Is Marinol Better Medicine Than Marijuana?
  2. Should Marijuana Be a Medical Option?
  3. Is Marijuana an Effective Treatment for Reducing Nausea and Vomiting from Chemotherapy?